The Lancet Oncology: September 02, 2013

from Listen to The Lancet Oncology · host The Lancet

Jesus San Miguel discusses a phase 3 trial comparing pomalidomide plus low-dose dexamethasone with high-dose dexamethasone in patients with multiple myeloma.

Episode metadata supplied by the publisher feed · Published Sep 2, 2013

Embed this episode

Attribution link and audio player

NOW PLAYING

The Lancet Oncology: September 02, 2013

0:00 7:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Oncology?

This episode is 7 minutes long.

When was this Listen to The Lancet Oncology episode published?

This episode was published on September 2, 2013.

Can I download this Listen to The Lancet Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!